Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vista Medical Technologies

This article was originally published in The Gray Sheet

Executive Summary

Slower than anticipated sales growth for the firm's advanced visualization and information integration platform used in minimally invasive surgical procedures is cited by the firm in announcing July 14 a headcount reduction and cuts in operating expenses. The firm, which went public via an initial stock offering in 1997 ("The Gray Sheet" March 17, 1997, p. 11), is seeking to raise capital "or to effect a sale or merger of the company"

You may also be interested in...



Jomed's $205 Mil. EndoSonics Buy Adds Direct Sales Reps, IVUS Platform

Jomed's $205 mil. acquisition of EndoSonics could create the necessary platform for use of intravascular ultrasound as a guide for interventional procedures to be adopted by the broader clinical community.

Jomed's $205 Mil. EndoSonics Buy Adds Direct Sales Reps, IVUS Platform

Jomed's $205 mil. acquisition of EndoSonics could create the necessary platform for use of intravascular ultrasound as a guide for interventional procedures to be adopted by the broader clinical community.

Vista Medical Technologies, Inc.

Files with SEC for a 7 mil.-share secondary offering. The Carlsbad, California maker of 3-D visualization equipment for minimally invasive surgery had announced in July a headcount and expense reduction effort and plans to seek additional capital, citing slower than anticipated sales growth for its advanced visualization and information integration platform (1"The Gray Sheet" July 19, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel